@misc{indiciaea722316712a4,
  title = {Combined in silico docking and in vitro antiviral testing for drug repurposing identified lurasidone and elbasvir as SARS-CoV-2 and HCoV-OC43 inhibitors},
  author = {Milani, M. and Donalisio, M. and Bonotto, R. M. and Schneider, E. and Arduino, I. and Boni, F. and Lembo, D. and Marcello, A. and Mastrangelo, E.},
  year = {2020},
  doi = {10.1101/2020.11.12.379958},
  url = {https://www.biorxiv.org/content/10.1101/2020.11.12.379958v1},
  note = {Source identifier: 10.1101/2020.11.12.379958}
}